Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK's HPA widens remit with top biologics R&D and standards body

This article was originally published in Clinica

Executive Summary

The UK's National Institute of Biological Standards (NIBSC) is to merge with the Health Protection Agency (HPA) in April 2009. The move will broaden the HPA's remit to cover safety in relation to the development and use of biological products, including those involving blood and tissues. The NISBC, which was behind the creation of the UK Stem Cell Bank, runs a "broad and vibrant research programme", produces "almost all the world's" international standards for biologics safety and effectiveness, and is said to be pre-eminent in areas of emerging importance, such as the H5N1 "avian flu" virus. The NIBSC's director, Stephen Inglis, spoke of the plans during the HPA's annual conference (University of Warwick, September 15-17).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043072

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel